The Tim Ferriss Show #377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
37 snips
Jul 15, 2019 
Ayelet Waldman, author of "A Really Good Day," shares her transformative experience with microdosing and its positive effects on her life. Robin Carhart-Harris, head of psychedelic research at Imperial College London, discusses the neurological mechanisms behind psychedelics and their therapeutic potential. Christian Angermayer, an investor in psychedelic innovations, highlights the shift in mental health treatment perspectives. The conversation explores microdosing’s role in combating depression, the opioid crisis, and the evolving legal landscape surrounding psychedelics.
AI Snips
Chapters
Books
Transcript
Episode notes
McCormick's Impact
- Catherine McCormick, a lesser-known figure, significantly impacted history by funding the development of the birth control pill.
- Her $2 million investment, equivalent to $23 million today, demonstrates the potential of an uncrowded bet.
Psilocybin for Cancer Patients
- Psilocybin shows promise in treating depression and anxiety associated with life-threatening cancer diagnoses.
- A single high dose can produce sustained reductions in symptoms for up to six months.
Waldman's Microdosing Experience
- Ayelet Waldman, experiencing severe depression, experimented with microdosing LSD for 30 days.
- She found profound effects, including increased appreciation of beauty, improved mood, and enhanced productivity.
